Based on our research, we estimate that the global investigative site community spent $170 million in 2024 to complete ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

SCOPE Conference (Summit for Clinical Ops Executives), held last week in Orlando, FL, brought together more than 4,500 industry ...

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

Kenya is one of the largest refugee hosting countries in Africa, with over 800 000 refugees and asylum seekers. Forty percent ...

Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness ...

Maze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...

CVS’s VP and head of decentralised clinical trials, site solutions, and strategy, to talk about the venture and lessons learned in the first year. This interview has been edited for length and ...

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...